PANDICA

At PANDICA, we have developed a groundbreaking range of devices, PandiCath®. These versatile tools are designed to meet critical unmet needs in diagnosing and treating severe conditions of the gastrointestinal (GI) and pancreato-biliary systems. PandiCath® devices introduce a unique capability to create isolated areas within the GI tract with controlled conditions, such as active decompression, while simultaneously maintaining the tract's connectivity and functionality. This innovative approach supports prolonged and effective use, which is essential for various diagnostic and therapeutic applications. Effectiveness of PandiCath® has been demonstrated in treatment of acute pancreatitis, potentially fatal GI bleeding, GI fistulas and anastomotic leakages, chemical burns of esophagus, as well as in diagnosis and verification of mucinous neoplasms of the pancreas. Key Benefits of PandiCath®: 1) Life-Saving Potential: The use of PandiCath® devices in treating GI and pancreato-biliary conditions has the potential to save thousands of lives by providing timely and effective intervention. 2) Disease Severity Reduction: By enabling early and precise diagnostics and tailored treatments, these devices can significantly reduce the severity of diseases. 3) Cost Efficiency: Effective use of PandiCath® can lower the overall costs associated with treating GI and pancreato-biliary conditions by reducing the need for extensive surgical procedures and long-term hospital stays.

• Employees 5
• Founded 2019